CIDARA THERAPEUTICS, INC. Retained Earnings
CIDARA THERAPEUTICS, INC. had Retained Earnings of -$743.69 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-06
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$743.69M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$660.46M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$634.74M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$611.26M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-09-30 | -$743.69M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$660.46M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$634.74M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$611.26M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | -$558.95M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$542.97M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$451.76M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$441.43M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$438.22M 10-K · filed 2024-04-22 | -$424.29M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$429.11M 10-K · filed 2024-04-22 | -$416.11M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$415.49M 10-K · filed 2024-04-22 | -$403.76M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$418.50M 10-K · filed 2024-04-22 | -$406.97M 10-K · filed 2023-03-23 |
| 2022-09-30 | -$404.90M 10-K · filed 2024-04-22 | -$393.59M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$419.15M 10-K · filed 2024-04-22 | -$408.57M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$403.39M 10-K · filed 2024-04-22 | -$395.45M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$377.17M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$360.36M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$342.28M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$352.99M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$334.70M 10-K · filed 2022-03-07 | |
| 2020-09-30 | -$313.07M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$295.43M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | -$277.13M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | -$259.83M 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$245.80M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$248.84M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$235.30M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$218.74M 10-K · filed 2020-03-04 | |
| 2018-09-30 | -$206.39M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$192.77M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$166.14M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$149.39M 10-K · filed 2019-02-28 | |
| 2017-09-30 | -$135.96M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | -$123.70M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$107.06M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$93.66M 10-K · filed 2018-02-27 | |
| 2016-09-30 | -$79.27M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$67.04M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | -$55.29M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$45.50M 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$35.63M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$26.45M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | -$20.04M 10-Q · filed 2015-05-21 | |
| 2014-12-31 | -$13.30M 10-K · filed 2016-03-18 |